← Leaderboards
Phyllis A. Luvalle
University Of Florida
$1,431,152
Attributed
$1,431,152
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $295.2K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,431,152 · 1
By mechanism
R01$1,431,152 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Retinoblastoma Protein”
- Peter M Howley · Dana-Farber Cancer Inst$15,213,853
- Nicholas J Dyson · Massachusetts General Hospital$14,672,357
- William G Kaelin · Dana-Farber Cancer Institute$12,360,860
- Julien Sage · University Of California Santa Cruz$11,552,251
- Erik Knudsen · University Of Cincinnati$10,527,434
- Karl Munger · Harvard University (Medical School)$9,851,790
Research focus
Retinoblastoma ProteinGene ExpressionChondrocytesApoptosisAffectDna SequenceDwarfismCamp Response Element Binding ProteinBcl2 Gene /ProteinCartilaginous ExostosisCell CycleCell Cycle ProgressionCell Cycle ProteinsActivating Transcription Factor 2Bone MarrowActivation, GeneBone GrowthChondrogenic NeoplasmCyclic Amp Response ElementCyclin ACyclin D1DefectDegenerative PolyarthritisDesign
Grant awards (5)
Control of Skeletal Growth by ATF-2$273,554
R01 · FY2008 · AR · contact PI
Control of Skeletal Growth by ATF-2$279,529
R01 · FY2007 · AR · contact PI
Control of Skeletal Growth by ATF-2$287,878
R01 · FY2006 · AR · contact PI
Control of Skeletal Growth by ATF-2$295,220
R01 · FY2005 · AR
Control of Skeletal Growth by ATF-2$294,971
R01 · FY2004 · AR